FLUPROSTENOL

Test Ligands Values Explained

Test Ligand ID - A unique identifier for the test ligand
Ligand Name - Name of the test ligand

Test Ligand ID841
Ligand NameFLUPROSTENOL
PubMed Compound Id5311100
StructureProduct Image
Molecular FormulaC23H29F3O6
Molecular Weight458.5
SMILESC1[C@@H]([C@@H]([C@H]([C@@H]1O)/C=C/[C@H](COC2=CC=CC(=C2)C(F)(F)F)O)C/C=C\CCCC(=O)O)O
Synonymsfluprostenol
travoprost acid
(+)-fluprostenol
54276-17-4
40666-16-8
Fluprostenol, (+)-
travoprost free acid
Fluprostenolum
ICI 81,008
Fluoprostenol
EINECS 255-029-3
(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]cyclopentyl]hept-5-enoic acid
CHEBI:60782
MEH3MCE8X1
AL-5848
358S7VUE5N
5-Heptenoic acid, 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3R)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)-1-buten-1-yl)cyclopentyl)-, (5Z)-
DTXSID7046122
ICI-81008
NCGC00160386-01
ICI 81008
(5Z ,13E )-(9S,11R,15R )-9,11,15-Trihydroxy-16-(m-trifluoromethylphenoxy)-17,18,19,20-tetranor-5,13-prostadienoic acid
(Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R,E)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)but-1-en-1-yl)cyclopentyl)hept-5-enoic acid
rac-(5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-{(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-en-1-yl}cyclopentyl]hept-5-enoic acid
[3H](+)-fluprostenol
Fluprostenol [INN:BAN]
UNII-MEH3MCE8X1
[3H]-(+)-fluprostenol
Fluprostenolum [INN-Latin]
UNII-358S7VUE5N
(+/-)-Fluprostenol
(A+/-)-Fluprostenol
FLUPROSTENOL [MI]
FLUPROSTENOL [INN]
Fluprostenol Travoprost acid
BSPBio_001336
(5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-5-heptenoic Acid
SCHEMBL230607
BML2-G08
GTPL1940
GTPL3417
CHEMBL1201379
DTXCID5026122
ICI-80008 FREE ACID
Fluprostenol 10 mg/mL in ethanol
HMS1361C18
HMS1791C18
HMS1989C18
HMS3402C18
HMS3648H08
ICI 80,008 FREE ACID
(+/-)-16-(3-Trifluoromethylphenoxy)tetranorprostaglandin F2alpha
EX-A3612
Tox21_111778
BDBM50206025
MFCD03427566
16-(m-Trifluoromethylphenoxy)-17,18,19,20-tetranorprostaglandin F2alpha
AKOS024458212
DB11519
IDI1_033806
NCGC00160386-02
NCGC00160386-04
NCGC00160386-05
DA-68970
FF103958
MS-28380
CAS-40666-16-8
HY-108560
CS-0029169
G90905
SR-01000946504
SR-01000946504-1
BRD-K31611373-001-02-7
Q27077691
16-(M-TRIFLUOROMETHYLPHENOXY)-17,18,19,20-TETRANORPROSTAGLANDIN F2.ALPHA.
(+/-)-(Z)-7-((1R*,2R*,3R*,5S*)-3,5-DIHYDROXY-2-((E)-(3R*)-3-HYDROXY-4-((.ALPHA.,.ALPHA.,.ALPHA.-TRIFLUORO-M-TOLYL)OXY)-1-BUTENYL)CYCLOPENTYL)-5-HEPTENOATE
(5Z)-7-((1R,2R,3R,5S)-2-((R,E)-4-(3-(trifluoromethyl)phenoxy)-3-hydroxybut-1-enyl)-3,5-dihydroxycyclopentyl)hept-5-enoic acid
(5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-en-1-yl]cyclopentyl]hept-5-enoic acid
[1R-[1alpha(Z),2beta(1E,3R*),3alpha,5alpha]]-7-[3,5-Dihydroxy-2-[3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-5-heptenoic Acid
5-HEPTENOIC ACID, 7-((1R,2R,3R,5S)-3,5-DIHYDROXY-2-((1E,3R)-3-HYDROXY-4-(3-(TRIFLUOROMETHYL)PHENOXY)-1-BUTEN-1-YL)CYCLOPENTYL)-, (5Z)-REL-
5-HEPTENOIC ACID, 7-(3,5-DIHYDROXY-2-(3-HYDROXY-4-(3-(TRIFLUOROMETHYL)PHENOXY)-1-BUTENYL)CYCLOPENTYL)-(1.ALPHA.(Z),2.BETA.(1E,3R*),3.ALPHA.,5.ALPHA.)-,(+/-)-
5-HEPTENOIC ACID, 7-(3,5-DIHYDROXY-2-(3-HYDROXY-4-(3-(TRIFLUOROMETHYL)PHENOXY)-1-BUTENYL)CYCLOPENTYL)-, (1.ALPHA.(Z),2.BETA.(1E,3R*),3.ALPHA.,5.ALPHA.)-
Created AtJan 13, 2025 2:47 pm
Updated AtJan 13, 2025 2:47 pm